Fate Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Drives Share Gains MRCC Q4 2025 Earnings EPS Surpasses Estimates by Nearly 20 Shares Unchanged CNTA Q1 2026 Earnings WiderThanExpected Loss Reflects RD Investment Catheter Precision Inc VTAK Q1 2025 Earnings Significant EPS Miss and No Revenue Reported WRBY Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Growth Initiatives QUBT Q1 2026 Earnings Surprise EPS Beat Amid Continued PreRevenue Status GRO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Potash Developer Advances Project BDCIU Q1 2026 Earnings Positive EPS of 005 Reported Amid No Revenue Disclosure BOBS Q1 2026 Earnings EPS Beats Estimates by 40 But Stock Dips on Uncertain Outlook